Sam Ultraman Returns to OpenAI CEO Position Microsoft Will Get a Non Voting Observer Seat on the Board of Directors
寒江雪176
发表于 2023-11-30 10:17:38
1339
0
0
OpenAI founder Sam Ultraman announced in a memo on November 29th local time that he will re serve as CEO of OpenAI, and former CEO Mira Murati will continue to serve as Chief Technology Officer. Microsoft will receive a non voting observer seat on the company's board of directors.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Sam Ultraman and former Apple designer Avi are reportedly inviting Apple product design executives to develop artificial intelligence devices
- Microsoft Vice President Templeton is reported to have joined the OpenAI board as a non voting observer
- Microsoft Vice President joins the OpenAI Board of Directors as an observer without voting rights
- Opening a New Store in South China, Sam Promotes National Free Shipping: Foreign Membership Store Giants Grab "Middle Class Wallets" in China
- Costco's first store in South China opened online delivery service, but still unable to compete with Sam's
- Hand to hand combat with Sam! Exploring the First Weekend of Opening the South China First Store of Market Customers: No screening unless there is a cooling trend in the popularity of the member population
- What else does Sam Ultraman need besides trillions of dollars to reshape the semiconductor industry?
- Wal Mart's slowing growth in China has an impact on Sam's "relocation"
- Trigger the 'Sam Rule'! Trader: 100% probability of interest rate cut
- Alibaba 1688 offline store is here! Benchmarking against Sam and Costco!
-
アップル(AAPL)は現地時間10月31日、9月28日までの2024年第4四半期の業績を発表し、同四半期の売上高は前年同期比6%増の949億3000万ドル、純利益は同36%減の147億3600万ドルだった。 純利益の下落は主に102億ドル ...
- 亲亲宝宝贝贝贾
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 半小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 2 小时前
- 支持
- 反对
- 回复
- 收藏